In vitro Efficacy of Novel Glucan Synthase Inhibitor, Ibrexafungerp (SCY-078), Against Multidrug- and Pan-resistant Candida auris Isolates from the Outbreak in New York
Y. C. Zhu, S. A. Barat, K. Borroto-Esoda, D. Angulo, S. Chaturvedi, V. Chaturvedi
The paper evaluates the efficacy of the novel glucan synthase inhibitor Ibrexafungerp against multidrug-resistant Candida auris isolates from a New York outbreak, finding it effective with low MIC50 values.
bioRxiv · Oct 21, 2019Microbiology